{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:08:45Z","timestamp":1779023325669,"version":"3.51.4"},"reference-count":71,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-108-2321-B-005-010-MY3"],"award-info":[{"award-number":["MOST-108-2321-B-005-010-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.01.032","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T18:27:44Z","timestamp":1612031264000},"page":"1072-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP"],"prefix":"10.34133","volume":"19","author":[{"given":"Yeu-Yang","family":"Tseng","sequence":"first","affiliation":[{"name":"WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Ru","family":"Liao","sequence":"additional","affiliation":[{"name":"Graduate Institute of Microbiology and Public Health, National Chung Hsing University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Lien","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Washington, Seattle, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Microbiology and Public Health, National Chung Hsing University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.aivir.2018.01.001"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13410-1"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12879-017-2712-2","article-title":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients","volume":"17","author":"Ahmed A.E.","year":"2017","unstructured":"Ahmed A.E.: The predictors of 3- and 30-day mortality in 660 MERS-CoV patients. BMC Infect Dis 2017; 17: 615.","journal-title":"BMC Infect Dis"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_3_7_2","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","author":"Baden L.R.","year":"2020","unstructured":"Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., McGettigan J., Kehtan S., Segall N., Solis J., Brosz A., Fierro C., Schwartz H., Neuzil K., Corey L., Gilbert P., Janes H., Follmann D., Marovich M., Mascola J., Polakowski L., Ledgerwood J., Graham B.S., Bennett H., Pajon R., Knightly C., Leav B., Deng W., Zhou H., Han S., Ivarsson M., Miller J., Zaks T. and Group C.S.: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2020; .","journal-title":"N Engl J Med"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"e_1_3_3_9_2","article-title":"Molecular mechanism of evolution and human infection with SARS-CoV-2","volume":"12","author":"He J.","year":"2020","unstructured":"He J., Tao H., Yan Y., Huang S.Y. and Xiao Y.: Molecular mechanism of evolution and human infection with SARS-CoV-2. Viruses 2020; 12.","journal-title":"Viruses"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0485-4"},{"key":"e_1_3_3_11_2","first-page":"1","article-title":"Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening","author":"de Oliveira O.V.","year":"2020","unstructured":"de Oliveira O.V., Rocha G.B., Paluch A.S. and Costa L.T.: Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. J Biomol Struct Dyn 2020; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_3_12_2","first-page":"1","article-title":"Stilbene-based natural compounds as promising drug candidates against COVID-19","author":"Wahedi H.M.","year":"2020","unstructured":"Wahedi H.M., Ahmad S. and Abbasi S.W.: Stilbene-based natural compounds as promising drug candidates against COVID-19. J Biomol Struct Dyn 2020; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-004-4586-9"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00647-20","article-title":"The nucleocapsid protein of SARS-CoV-2: a target for vaccine development","volume":"94","author":"Dutta N.K.","year":"2020","unstructured":"Dutta N.K., Mazumdar K., Gordy J.T. and Dutch R.E.: The nucleocapsid protein of SARS-CoV-2: a target for vaccine development. J Virol 2020; 94.","journal-title":"J Virol"},{"key":"e_1_3_3_15_2","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","author":"Kang S.","year":"2020","unstructured":"Kang S., Yang M., Hong Z., Zhang L., Huang Z., Chen X., He S., Zhou Z., Zhou Z., Chen Q., Yan Y., Zhang C., Shan H. and Chen S.: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B 2020; .","journal-title":"Acta Pharm Sin B"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/v6082991"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1128\/jvi.70.7.4773-4777.1996","article-title":"The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins","volume":"70","author":"Risco C.","year":"1996","unstructured":"Risco C., Anton I.M., Enjuanes L. and Carrascosa J.L.: The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins. J Virol 1996; 70: 4773.","journal-title":"J Virol"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/JVI.75.3.1312-1324.2001","article-title":"The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability","volume":"75","author":"Escors D.","year":"2001","unstructured":"Escors D., Ortego J., Laude H. and Enjuanes L.: The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol 2001; 75: 1312.","journal-title":"J Virol"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1128\/JVI.76.10.4987-4999.2002","article-title":"Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus","volume":"76","author":"Kuo L.","year":"2002","unstructured":"Kuo L. and Masters P.S.: Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol 2002; 76: 4987.","journal-title":"J Virol"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.02.074"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501015200"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.03.154"},{"key":"e_1_3_3_23_2","first-page":"181","article-title":"High affinity interaction between nucleocapsid protein and leader\/intergenic sequence of mouse hepatitis virus RNA","volume":"81","author":"Nelson G.W.","year":"2000","unstructured":"Nelson G.W., Stohlman S.A. and Tahara S.M.: High affinity interaction between nucleocapsid protein and leader\/intergenic sequence of mouse hepatitis virus RNA. J Gen Virol 2000; 81: 181.","journal-title":"J Gen Virol"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1128\/jvi.62.11.4280-4287.1988","article-title":"Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription","volume":"62","author":"Baric R.S.","year":"1988","unstructured":"Baric R.S., Nelson G.W., Fleming J.O., Deans R.J., Keck J.G., Casteel N. and Stohlman S.A.: Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol 1988; 62: 4280.","journal-title":"J Virol"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1099\/0022-1317-39-3-545","article-title":"Ribonucleoprotein-like structures from coronavirus particles","volume":"39","author":"Macneughton M.R.","year":"1978","unstructured":"Macneughton M.R. and Davies H.A.: Ribonucleoprotein-like structures from coronavirus particles. J Gen Virol 1978; 39: 545.","journal-title":"J Gen Virol"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.2.1164-1179.2005"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1099\/0022-1317-53-1-67","article-title":"Ribonucleoprotein of avian infectious bronchitis virus","volume":"53","author":"Davies H.A.","year":"1981","unstructured":"Davies H.A., Dourmashkin R.R. and Macnaughton M.R.: Ribonucleoprotein of avian infectious bronchitis virus. J Gen Virol 1981; 53: 67.","journal-title":"J Gen Virol"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/JVI.01906-07","article-title":"Envelope protein palmitoylations are crucial for murine coronavirus assembly","volume":"82","author":"Boscarino J.A.","year":"2008","unstructured":"Boscarino J.A., Logan H.L., Lacny J.J. and Gallagher T.M.: Envelope protein palmitoylations are crucial for murine coronavirus assembly. J Virol 2008; 82: 2989.","journal-title":"J Virol"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01052-08"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/JVI.01570-10","article-title":"The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus","volume":"85","author":"Ruch T.R.","year":"2011","unstructured":"Ruch T.R. and Machamer C.E.: The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus. J Virol 2011; 85: 675.","journal-title":"J Virol"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/v4030363"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1074\/jbc.M509233200","article-title":"The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells","volume":"281","author":"Surjit M.","year":"2006","unstructured":"Surjit M., Liu B., Chow V.T.K. and Lal S.K.: The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem 2006; 281: 10669.","journal-title":"J Biol Chem"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01782-06"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.02.069"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.17.11476-11486.2005"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02001-08"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm500089r"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi036155b"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bbapap.2013.03.003","article-title":"Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein","volume":"1834","author":"Chen I.-J.","year":"2013","unstructured":"Chen I.-J., Yuann J.-M., Chang Y.-M., Lin S.-Y., Zhao J., Perlman S. et al: Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein. Biochim Biophys Acta 2013; 1834: 1054.","journal-title":"Biochim Biophys Acta"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.09.040"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1093\/nar\/gkl650","article-title":"Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells","volume":"34","author":"Tan Y.W.","year":"2006","unstructured":"Tan Y.W., Fang S., Fan H., Lescar J. and Liu D.X.: Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells. Nucleic Acids Res 2006; 34: 4816.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi0609319"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2004.06.008"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02236-06"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1039\/C5MB00582E","article-title":"Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein","volume":"12","author":"Chang C.K.","year":"2016","unstructured":"Chang C.K., Jeyachandran S., Hu N.J., Liu C.L., Lin S.Y., Wang Y.S. et al: Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein. Mol Biosyst 2016; 12: 59.","journal-title":"Mol Biosyst"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2147\/IJN.S31379","article-title":"A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide","volume":"7","author":"Roh C.","year":"2012","unstructured":"Roh C.: A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int J Nanomed 2012; 7: 2173.","journal-title":"Int J Nanomed"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2006.08.016","article-title":"Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy","volume":"118","author":"Williamson M.P.","year":"2006","unstructured":"Williamson M.P., McCormick T.G., Nance C.L. and Shearer W.T.: Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol 2006; 118: 1369.","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1021\/jp0550762"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/acs.jmedchem.9b01913","article-title":"Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design","volume":"63","author":"Lin S.M.","year":"2020","unstructured":"Lin S.M., Lin S.C., Hsu J.N., Chang C.K., Chien C.M., Wang Y.S. et al: Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design. J Med Chem 2020; 63: 3131.","journal-title":"J Med Chem"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00120"},{"key":"e_1_3_3_51_2","first-page":"1","article-title":"In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)","author":"Sarma P.","year":"2020","unstructured":"Sarma P., Shekhar N., Prajapat M., Avti P., Kaur H., Kumar S., Singh S., Kumar H., Prakash A., Dhibar D.P. and Medhi B.: In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn 2020; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_3_52_2","first-page":"1","article-title":"Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2","author":"Yadav R.","year":"2020","unstructured":"Yadav R., Imran M., Dhamija P., Suchal K. and Handu S.: Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2. J Biomol Struct Dyn 2020; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7774\/cevr.2015.4.2.166","article-title":"Porcine epidemic diarrhea: a review of current epidemiology and available vaccines","volume":"4","author":"Song D.","year":"2015","unstructured":"Song D., Moon H. and Kang B.: Porcine epidemic diarrhea: a review of current epidemiology and available vaccines. Clin Exp Vaccine Res 2015; 4: 166.","journal-title":"Clin Exp Vaccine Res"},{"key":"e_1_3_3_54_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3201\/eid2201.150544","article-title":"Porcine epidemic diarrhea virus and discovery of a recombinant swine enteric coronavirus, Italy","volume":"22","author":"Boniotti M.B.","year":"2016","unstructured":"Boniotti M.B., Papetti A., Lavazza A., Alborali G., Sozzi E., Chiapponi C. et al: Porcine epidemic diarrhea virus and discovery of a recombinant swine enteric coronavirus, Italy. Emerg Infect Dis 2016; 22: 83.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10495398.2016.1232268","article-title":"Antiviral compounds against nucleocapsid protein of porcine epidemic diarrhea virus","volume":"28","author":"Deejai N.","year":"2017","unstructured":"Deejai N., Roshorm Y.M. and Kubera A.: Antiviral compounds against nucleocapsid protein of porcine epidemic diarrhea virus. Anim Biotechnol 2017; 28: 120.","journal-title":"Anim Biotechnol"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040173"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1707487"},{"key":"e_1_3_3_58_2","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s00253-019-09702-5","article-title":"Generation, identification, and functional analysis of monoclonal antibodies against porcine epidemic diarrhea virus nucleocapsid","volume":"103","author":"Yang W.","year":"2019","unstructured":"Yang W., Chen W., Huang J., Jin L., Zhou Y., Chen J. et al: Generation, identification, and functional analysis of monoclonal antibodies against porcine epidemic diarrhea virus nucleocapsid. Appl Microbiol Biotechnol 2019; 103: 3705.","journal-title":"Appl Microbiol Biotechnol"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","first-page":"197912","DOI":"10.1016\/j.virusres.2020.197912","article-title":"Identification and characterization of linear B cell epitopes on the nucleocapsid protein of porcine epidemic diarrhea virus using monoclonal antibodies","volume":"281","author":"Wang X.","year":"2020","unstructured":"Wang X., Fang L., Zhan J., Shi X., Liu Q., Lu Q. et al: Identification and characterization of linear B cell epitopes on the nucleocapsid protein of porcine epidemic diarrhea virus using monoclonal antibodies. Virus Res 2020; 281: 197912.","journal-title":"Virus Res"},{"key":"e_1_3_3_60_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.taap.2017.04.017","article-title":"Identification of anti-viral activity of the cardenolides, Na(+)\/K(+)-ATPase inhibitors, against porcine transmissible gastroenteritis virus","volume":"332","author":"Yang C.W.","year":"2017","unstructured":"Yang C.W., Chang H.Y., Hsu H.Y., Lee Y.Z., Chang H.S., Chen I.S. et al: Identification of anti-viral activity of the cardenolides, Na(+)\/K(+)-ATPase inhibitors, against porcine transmissible gastroenteritis virus. Toxicol Appl Pharmacol 2017; 332: 129.","journal-title":"Toxicol Appl Pharmacol"},{"key":"e_1_3_3_61_2","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1128\/AAC.00408-07","article-title":"Novel small-molecule inhibitors of transmissible gastroenteritis virus","volume":"51","author":"Yang C.W.","year":"2007","unstructured":"Yang C.W., Yang Y.N., Liang P.H., Chen C.M., Chen W.L., Chang H.Y. et al: Novel small-molecule inhibitors of transmissible gastroenteritis virus. Antimicrob Agents Chemother 2007; 51: 3924.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_3_62_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/07391102.2010.10507362","article-title":"Anti-infectious bronchitis virus (IBV) activity of 1,8-cineole: effect on nucleocapsid (N) protein","volume":"28","author":"Yang Z.","year":"2010","unstructured":"Yang Z., Wu N., Fu Y., Yang G., Wang W., Zu Y. et al: Anti-infectious bronchitis virus (IBV) activity of 1,8-cineole: effect on nucleocapsid (N) protein. J Biomol Struct Dyn 2010; 28: 323.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_3_63_2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/molecules16021044","article-title":"Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein","volume":"16","author":"Yang Z.","year":"2011","unstructured":"Yang Z., Wu N., Zu Y. and Fu Y.: Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein. Molecules 2011; 16: 1044.","journal-title":"Molecules"},{"key":"e_1_3_3_64_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1637\/7259-081104R","article-title":"In vitro analysis of a hammerhead ribozyme targeted to infectious bronchitis virus nucleocapsid mRNA","volume":"49","author":"Callison S.A.","year":"2005","unstructured":"Callison S.A., Hilt D.A. and Jackwood M.W.: In vitro analysis of a hammerhead ribozyme targeted to infectious bronchitis virus nucleocapsid mRNA. Avian Dis 2005; 49: 159.","journal-title":"Avian Dis"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.4.1840-1847.1993"},{"key":"e_1_3_3_66_2","first-page":"341","article-title":"A ribozyme targeted to RNA polymerase gene of infectious bursal disease virus effectively cleaves and inhibits expression of the viral gene product","volume":"43","author":"Akin A.","year":"1999","unstructured":"Akin A., Lin T.L. and Wu C.C.: A ribozyme targeted to RNA polymerase gene of infectious bursal disease virus effectively cleaves and inhibits expression of the viral gene product. Acta Virol 1999; 43: 341.","journal-title":"Acta Virol"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1089\/oli.1.1999.9.279"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310331"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.04.015"},{"key":"e_1_3_3_70_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tvjl.2014.04.016","article-title":"An update on feline infectious peritonitis: diagnostics and therapeutics","volume":"201","author":"Pedersen N.C.","year":"2014","unstructured":"Pedersen N.C.: An update on feline infectious peritonitis: diagnostics and therapeutics. Vet J 2014; 201: 133.","journal-title":"Vet J"},{"key":"e_1_3_3_71_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.vetmic.2011.01.023","article-title":"In vitro inhibition of feline coronavirus replication by small interfering RNAs","volume":"150","author":"McDonagh P.","year":"2011","unstructured":"McDonagh P., Sheehy P.A. and Norris J.M.: In vitro inhibition of feline coronavirus replication by small interfering RNAs. Vet Microbiol 2011; 150: 220.","journal-title":"Vet Microbiol"},{"key":"e_1_3_3_72_2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2460\/ajvr.75.9.828","article-title":"Effect of small interfering RNAs on in vitro replication and gene expression of feline coronavirus","volume":"75","author":"Anis E.A.","year":"2014","unstructured":"Anis E.A., Wilkes R.P., Kania S.A., Legendre A.M. and Kennedy M.A.: Effect of small interfering RNAs on in vitro replication and gene expression of feline coronavirus. Am J Vet Res 2014; 75: 828.","journal-title":"Am J Vet Res"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.01.032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:44:58Z","timestamp":1779021898000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.01.032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":71,"alternative-id":["10.1016\/j.csbj.2021.01.032"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.01.032","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}